Literature DB >> 6298472

Genetic variability of herpes simplex virus: development of a pathogenic variant during passaging of a nonpathogenic herpes simplex virus type 1 virus strain in mouse brain.

H C Kaerner, C H Schröder, A Ott-Hartmann, G Kümel, H Kirchner.   

Abstract

Herpes simplex virus type 1 ANG (HSV-1 ANG) is originally nonpathogenic for inbred mice upon intraperitoneal intravenous, or intravaginal inoculation. In contrast, mice died of encephalitis within 4 to 5 days after intracerebral inoculation with this strain. HSV-1 ANG was serially passaged in mouse brains. In two independent series, peripherally pathogenic virus variants had developed and accumulated in the virus progeny after 12 to 15 intracerebral passages. In mixed infections both nonpathogenic and pathogenic viruses replicated at the primary site of infection and spread to various organs. However, only the pathogenic phenotype could be recovered from the spinal cord and the brain. Comparison of the restriction enzyme cleavage patterns of pathogenic ANG and nonpathogenic ANG virus DNAs revealed distinct alterations in the S-segment (US) sequences bounded by coordinates 0.953 and 0.958 in the prototype orientation and by coordinates 0.862 to 0.867 in the IS orientation of the viral genome. However, it is not known whether these alterations are physiologically relevant to the observed changes in pathogenicity. When coinjected intraperitoneally at 50 to 100-fold excess, the nonpathogenic HSV-1 ANG protected mice against its own pathogenic variant as well as against other pathogenic HSV-1 strains. Pathogenic HSV-1 ANG proved to be genetically and phenotypically stable for at least 25 serial passages in tissue culture at either high or low multiplicity of infection.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6298472      PMCID: PMC255095     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

1.  Structure and function of herpesvirus genomes. I. comparison of five HSV-1 and two HSV-2 strains by cleavage their DNA with eco R I restriction endonuclease.

Authors:  J Skare; W P Summers; W C Summers
Journal:  J Virol       Date:  1975-04       Impact factor: 5.103

2.  Anatomy of herpes simplex virus DNA: strain differences and heterogeneity in the locations of restriction endonuclease cleavage sites.

Authors:  G S Hayward; N Frenkel; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  1975-05       Impact factor: 11.205

3.  Genetics of natural resistance to herpesvirus infections in mice.

Authors:  C Lopez
Journal:  Nature       Date:  1975-11-13       Impact factor: 49.962

4.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

5.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

6.  The pathogenicity of thymidine kinase-deficient mutants of herpes simplex virus in mice.

Authors:  H J Field; P Wildy
Journal:  J Hyg (Lond)       Date:  1978-10

7.  Selective effects of anti-macrophage serum, silica and anti-lymphocyte serum on pathogenesis of herpes virus infection of young adult mice.

Authors:  B Zisman; M S Hirsch; A C Allison
Journal:  J Immunol       Date:  1970-05       Impact factor: 5.422

8.  Immunological studies of hsv-infection of resistant and susceptible inbred strains of mice.

Authors:  H Kirschner; M Kochen; H M Hirt; K Munk
Journal:  Z Immunitatsforsch Immunobiol       Date:  1978-03

9.  Acute and recurrent infection with herpes simplex virus in the mouse: a model for studying latency and recurrent disease.

Authors:  T J Hill; H J Field; W A Blyth
Journal:  J Gen Virol       Date:  1975-09       Impact factor: 3.891

10.  Restriction of herpes simplex virus by macrophages. An analysis of the cell-virus interaction.

Authors:  J G Stevens; M L Cook
Journal:  J Exp Med       Date:  1971-01-01       Impact factor: 14.307

View more
  23 in total

1.  Therapeutic Options for Herpes Simplex Infections.

Authors:  Eugene Au; Stephen L. Sacks
Journal:  Curr Infect Dis Rep       Date:  2003-02       Impact factor: 3.725

Review 2.  Herpes simplex viruses: is a vaccine tenable?

Authors:  Richard J Whitley; Bernard Roizman
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

3.  Cellular proteasome activity facilitates herpes simplex virus entry at a postpenetration step.

Authors:  Mark G Delboy; Devin G Roller; Anthony V Nicola
Journal:  J Virol       Date:  2008-01-30       Impact factor: 5.103

4.  Involvement of actin-containing microfilaments in HSV-induced cytopathology and the influence of inhibitors of glycosylation.

Authors:  U Heeg; H P Dienes; S Müller; D Falke
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

5.  Genetic and biological analyses of a herpes simplex virus intertypic recombinant reduced specifically for neurovirulence.

Authors:  R T Javier; R L Thompson; J G Stevens
Journal:  J Virol       Date:  1987-06       Impact factor: 5.103

6.  Autonomic nervous system involvement in experimental genital infection by herpes simplex virus type 2.

Authors:  N A Sanjuan; E F Lascano
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

7.  Colonization of adrenal glands and ovaries of mice by variants of HSV 1 and 2. II. Histopathological, immunohistochemical and in situ hybridization studies.

Authors:  H Wiegand; H P Dienes; P Schirmacher; J Podlech; K Bohl; M Bohle; D Neumann-Haefelin; D Falke
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

8.  Replication of HSV-1 in murine peritoneal macrophages: comparison of various virus strains with different properties.

Authors:  J Görtz; B Brake; V Härle-Grupp; D Falke
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

9.  The UL45 gene product is required for herpes simplex virus type 1 glycoprotein B-induced fusion.

Authors:  E J Haanes; C M Nelson; C L Soule; J L Goodman
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

10.  The pathogenicity of a US3 protein kinase-deficient mutant of herpes simplex virus type 2 in mice.

Authors:  R Kurachi; T Daikoku; T Tsurumi; K Maeno; Y Nishiyama; T Kurata
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.